Tuberculosis (TB)

World TB Day 2018 - Wanted: Leaders for a TB-free world

01 March 2018 - The theme of World TB Day 2018, “Wanted: Leaders for a TB-free world”, focuses on building commitment to end TB, not only at the political level with Heads of State and Ministers of Health, but at all levels from Mayors, Governors, parliamentarians and community leaders, to people affected with TB, civil society advocates, health workers, doctors or nurses, NGOs and other partners. All can be leaders of efforts to end TB in their own work or terrain.

WHO and USAID release guide to support countries in developing national action plans on public-private mix for TB prevention and care

23 February 2018 – The World Health Organization and the United States Agency for International Development (USAID) have released a new guide to help countries strategically and systematically scale-up the engagement of all care providers in TB prevention and care.

WHO issues new recommendations calling for accelerated uptake of testing and treatment for TB prevention

22 February 2018 – The World Health Organization (WHO) recommends scaling up access to testing and treatment for TB infection, especially among groups who are particularly at risk, such as small children and people living with HIV. The move will expand access to testing and care for people with latent TB infection (LTBI). People with latent TB may develop active TB in the future if they do not receive appropriate treatment.

WHO Executive Board adopts resolution on upcoming UN General Assembly high-level meeting on TB

26 January 2018 - Countries and partners at the 142nd World Health Organization (WHO) Executive Board (EB), adopted a Resolution yesterday in support of the upcoming UN General Assembly high-level meeting (UNHLM) on tuberculosis (TB). The Resolution included a request to WHO to work with key stakeholders to develop a draft TB multisectoral accountability framework to enable the monitoring, reporting, review and actions needed for greater accountability and impact, for consideration by the 71st World Health Assembly (WHA) in May 2018 and presentation during the UNHLM on TB.

WHO releases new handbook on digital technologies to support TB treatment adherence

24 January 2018 - Advances in mobile technologies, network coverage and internet access have transformed the way we interact with each other. These developments create novel possibilities to improve patient care, and reduce patient and health system costs. They have the potential to advance the notion of patient-centred care, bringing it within reach of many low resource settings. The Global TB Programme of the World Health Organization (WHO), in close collaboration with the European Respiratory Society (ERS), other technical partners and national tuberculosis programme staff, is releasing a practical manual on the use of digital technologies to support TB medication adherence.

WHO leadership meets with TB civil society to strengthen engagement in accelerating the End TB response

17 January 2018 – Civil society representatives met with WHO leadership in Geneva, on 15-16 January 2018, with the aim of strengthening collaboration to end TB. WHO Director-General Dr Tedros Adhanom Ghebreyesus and Dr Tereza Kasaeva, Director of the WHO Global TB Programme, opened the meeting, and Dr Soumya Swaminathan, Deputy Director-General, Dr Ren Minghui, Assistant Director General for the Cluster for Communicable Diseases, Dr Berhard Schwartlander, Chef de Cabinet, and Dr Lucica Ditiu, Executive Director of the Stop TB Partnership all expressed support for a much closer working relationship.

WHO issues a position statement on the use of delamanid for MDR-TB following an expedited review of phase III clinical trial results

15 January 2018 – The WHO Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB), following an expedited review of the phase III randomized controlled trial results released at the 48th UNION World Conference on Lung Health in Mexico by Otsuka Pharmaceutical. "This trial is the first-ever MDR-TB treatment study of its kind to be completed and reported and its findings were thus much-awaited," said Dr Tereza Kasaeva, Director of the Global TB Programme.

fact buffet

Lives saved

53 millionlives were saved through effective diagnosis and treatment, 2000-2016.

Fact sheet on tuberculosis

MDR-TB cases

490 000people developed multidrug-resistant tuberculosis (MDR-TB) in the world in 2016, an additional 110 000 people with rifampicin-resistant TB also required second line treatment in 2016.



2.3 billionUS dollars per year needed to fill resource gap for implementing existing TB interventions.

Global TB report facts
pdf, 592kb

Global Ministerial Conference

The Global Ministerial Conference “Ending TB in the Sustainable Development Era: A Multisectoral Response” aims to accelerate country implementation of the WHO End TB Strategy in order to reach the End TB targets set by the World Health Assembly and the United Nations (UN) Sustainable Development Goals (SDGs). The Ministerial Conference will inform the UN General Assembly High-Level Meeting on TB in 2018.”

A group portrait.

The strategy aims to end the global TB epidemic, with targets to reduce TB deaths by 95% and to cut new cases by 90% between 2015 and 2035, and to ensure that no family is burdened with catastrophic expenses due to TB.

World TB day

World TB Day is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and control efforts.

Advisory bodies

Activities of the Strategic and Technical Advisory Group for TB (STAG-TB), Task Force on TB Impact Measurement, Latent TB Infection Task Force, HIV/TB Task Force and the Task Force for New Drug Policy Development.

Emma Thompson, the British actress and Mayor of London’s TB Ambassador, speaking out on the importance of joining WHO and its partners to end tuberculosis, which kills over 4,000 people each day.